SNDX

Syndax Pharmaceuticals (SNDX)

About Syndax Pharmaceuticals (SNDX)

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Details

Daily high

$20.00

Daily low

$19.21

Price at open

52 Week High

$25.59

52 Week Low

$8.58

Market cap

1.7B

Dividend yield

0.00%

Volume

2,051

Avg. volume

2.0M

P/E ratio

-7.02

Syndax Pharmaceuticals News